Alto logoCompany profile

Alto

Alto, a San Francisco-based digital pharmacy founded in 2015, has raised $592 million across multiple funding rounds, achieving a $1 billion valuation after its $200 million Series E round in January 2022, led by SoftBank Vision Fund. Other key investors include Greenoaks, Jackson Square Ventures, and Meritech Capital. Alto’s platform combines expert pharmacist care, prescription management, and same-day delivery to simplify access to and affordability of medications. With over 1,400 employees, the company is reshaping how patients and healthcare providers manage prescriptions digitally.

Back to profiles

Quick facts

Total funding
$592 million
Valuation
$1 billion
Founded
2015
Employees
1,400

Notable investors

  • Greenoaks
  • Jackson Square Ventures
  • Meritech Capital
  • SoftBank Vision Fund

Reach buyers like Alto.

The 14-day trial ships every feature, no card required.